Fangdd Network Group Ltd. announced that the Company?s board of directors has appointed Mr. Jun Luo as a director of the Company, the chairman of the Nominating and Corporate Governance Committee, a member of the Compensation Committee, and a member of the Audit Committee, to succeed Mr. Zhen Xie, who has resigned from these positions for personal reasons. These Board and committee changes became effective as of June 10, 2024. Mr. Jun Luo has extensive experience in operational planning and investment management.

Mr. Luo is currently the co-vice chairman of the board of directors and the chief executive officer of Kaisa Health Group Holdings Ltd. From May 2018 to October 2023, Mr. Luo served as a director of Pacific Shuanglin Bio-pharmacy Co. Ltd. Mr. Luo obtained his bachelor?s degree in management from Nanjing University of Finance & Economics in 2003 and a master?s degree in business administration from Tongji University. The Board has determined that Mr. Jun Luo satisfies the independence requirements of Rule 5605(c)(2) of the Listing Rules of the Nasdaq Stock Market and Rule 10A-3 under the Securities Exchange Act of 1934, as amended.